Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01083147

Acronym

AMD

Enrollment

Registered

2010-03-09

Start date

2009-10-31

Completion date

2010-09-30

Last updated

2010-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Keywords

Intermediate AMD

Brief summary

The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.

Detailed description

This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.

Interventions

DEVICEFORESEE HOME

Home Monitoring

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects who successfully completed participation in ForeseeHome-US2 study * Patients with ability to comprehend and sign the informed consent/authorization

Exclusion criteria

* Subjects who failed to complete participation in ForeseeHome-US2 study

Design outcomes

Primary

Measure	Time frame
Subject compliance with Foresee HomeTM device	6 months

Secondary

Measure	Time frame
Assessment of the Telemedicine infrastructure	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026